Darbepoetin Alfa Injection

Darbepoetin Alfa Injection

Categories : Hematology

Product Packaging : 0.40 ml

Product Composition : 20 mcg / 40 mcg

Darbepoetin Alfa Injection is a recombinant protein therapy used to treat anemia in patients with chronic kidney disease (CKD) and those receiving chemotherapy. This injectable helps increase hemoglobin production naturally, reduce fatigue, and enhance overall vitality.

Genliva Wellness LLP is a reputed Darbepoetin Alfa Injection manufacturer in India, specializing in sterile, high-purity injectables for domestic and international markets. As a trusted exporter and contract manufacturing partner, Genliva provides bulk supply, private labeling, and hospital-ready formulations.

The injection is widely used in renal care and oncology centers, ensuring effective anemia management with consistent therapeutic outcomes.

Send Message

Darbepoetin Alfa Injection is a recombinant protein therapy used to treat anemia in patients with chronic kidney disease (CKD) and those receiving chemotherapy. This injectable helps increase hemoglobin production naturally, reduce fatigue, and enhance overall vitality.

Genliva Wellness LLP is a reputed Darbepoetin Alfa Injection manufacturer in India, specializing in sterile, high-purity injectables for domestic and international markets. As a trusted exporter and contract manufacturing partner, Genliva provides bulk supply, private labeling, and hospital-ready formulations.

The injection is widely used in renal care and oncology centers, ensuring effective anemia management with consistent therapeutic outcomes.

  • High-purity Darbepoetin Alfa Injection manufactured in India under GMP guidelines
  • Supports natural red blood cell production
  • Available in multiple vial sizes and concentrations
  • Ideal for CKD and chemotherapy-induced anemia treatment
  • Suitable for bulk supply and private labeling projects
  • Backed by regulatory approvals, quality certifications, and COA
  • Compatible with hospital, dialysis, and cancer care facilities
  • Flexible for third-party and contract manufacturing collaborations
  • Treating anemia in chronic kidney disease patients
  • Managing chemotherapy-related anemia
  • Minimizing the need for blood transfusions
  • Supporting improved oxygen transport and energy levels
  • Adjunct therapy in renal therapy and oncology care plans
  • Enhancing overall quality of life in anemia patients
  • Injectable form provides precise, fast-acting results
  • Suitable for in-clinic, hospital, and outpatient administration
  • Stable for transport and storage in controlled conditions
  • Compatible with vials, prefilled syringes, and export packaging
  • Economical solution for institutional procurement and international distribution

whatsapp-app